Interspecies Recombination in Type II Topoisomerase Genes Is Not a Major Cause of Fluoroquinolone Resistance in Invasive Streptococcus pneumoniae Isolates in the United States
Open Access
- 1 February 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (2) , 779-780
Abstract
Mutations in the topoisomerase type II enzymes account for fluoroquinolone resistance in Streptococcus pneumoniae . These mutations can arise spontaneously or be transferred by intraspecies or interspecies recombination, primarily with viridans streptococci. We analyzed the nucleotide sequences of the quinolone resistance-determining regions of 49 invasive levofloxacin-resistant pneumococcal isolates and did not find any evidence for interspecies recombination.Keywords
This publication has 11 references indexed in Scilit:
- Levofloxacin-Resistant Invasive Streptococcus pneumoniae in the United States: Evidence for Clonal Spread and the Impact of Conjugate Pneumococcal VaccineAntimicrobial Agents and Chemotherapy, 2004
- Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in BelgiumJournal of Antimicrobial Chemotherapy, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2003
- Emergence of a Novel Penicillin‐Nonsusceptible, Invasive Serotype 35B Clone ofStreptococcus pneumoniaewithin the United StatesThe Journal of Infectious Diseases, 2002
- Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Mosaic Genes and Mosaic Chromosomes: Intra- and Interspecies Genomic Variation of Streptococcus pneumoniaeInfection and Immunity, 2001
- Drug Efflux and parC Mutations Are Involved in Fluoroquinolone Resistance in Viridans Group StreptococciAntimicrobial Agents and Chemotherapy, 1999
- In Vitro Exchange of Fluoroquinolone Resistance Determinants betweenStreptococcus pneumoniaeand Viridans Streptococci and Genomic Organization of theparE‐parCRegion inS. mitisThe Journal of Infectious Diseases, 1999
- Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1996